CMPX
Compass Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.90
+2.70%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $229.3K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.13
- EPS estimate
- -$0.11
- Revenue actual
- —
- Revenue estimate
- -$600.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +7.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.11 | -$0.13 | Miss -17.47% | — |
| May 5, 2026 | -$0.10 | -$0.10 | In line | — |
| Mar 5, 2026 | -$0.09 | -$0.09 | Beat 4.21% | — |
| Nov 5, 2025 | -$0.14 | -$0.08 | Beat 42.86% | — |
| May 8, 2025 | -$0.12 | -$0.12 | In line | — |
| Feb 27, 2025 | -$0.10 | -$0.11 | Miss -10.00% | — |
| Mar 21, 2024 | -$0.09 | -$0.11 | Miss -22.22% | $2.8M |
| Nov 9, 2023 | -$0.11 | -$0.08 | Beat 27.27% | — |
| Aug 3, 2023 | -$0.08 | -$0.09 | Miss -12.50% | — |
| May 4, 2023 | -$0.11 | -$0.06 | Beat 45.45% | — |
| Mar 15, 2023 | -$0.11 | -$0.10 | Beat 9.09% | — |
| Nov 9, 2022 | -$0.11 | -$0.12 | Miss -9.09% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026